| Dr. Suresh Koolwal |
2014 |
Koolwal, Dr. Suresh. “A Rare Case of Ulcerative Colitis with Diffuse Parenchymal Lung Disease, Spontaneous Pneumomediastinum and Subcutaneous Emphysema.” The Indian Journal of Chest Diseases & Allied Sciences, University of Delhi, 2014. |
| Dr. Suresh Koolwal |
2018 |
A Rare Differential Diagnosis of Crazy Paving Pattern, Indian Journal of Medical and Pediatric Oncology 2018; 39(03): 415-416 |
| Dr. Suresh Koolwal |
2018 |
Study of iron metabolism in pulmonary tuberculosis patients. Int J Health Sci Res. 2018; 8(3):70-77. |
| Dr. Suresh Koolwal |
2018 |
Ionic Calcium verses Total Calcium in Relation to Disease Severity and Inflammation in Pulmonary Tuberculosis, International Journal of Medical Science and Current Research | November-December 2018 | Vol 1 | Issue 4 |
| Dr. Suresh Koolwal |
2019 |
Bronchoscopy lung cryobiopsy: An Indian association for bronchology position statement, Lung India 2019-volume 36, issue-1, pg. 48-59 |
| Dr. Suresh Koolwal |
2019 |
Identifying the Factors Increasing the Yield of Closed Pleural Biopsy in Undiagnosed Exudative Pleural Effusion, The RMJ Issue Jan 2019 |
| Dr. Suresh Koolwal |
2020 |
A study of modified DECAF score in predicting hospital outcomes in patients of acute exacerbation of chronic obstructive pulmonary disease at SMS medical college, Jaipur. Adv Hum Biol 2020; 10:171-5 |
| Dr. Suresh Koolwal |
2020 |
Bronchogenic Carcinoma: Endoscopy versus Histopathology: Journal of Clinical and Diagnostic Research. 2020 Aug, Vol-14(8): OC19-OC24 |
| Dr. Suresh Koolwal |
2021 |
Screening of healthcare and non-healthcare workers for prevalence of latent tuberculosis infection at tertiary care center Jaipur, Rajasthan – Paripax- Indian journal of research | Volume - 10 | Issue - 05 |May - 2021 | |
| Dr. Suresh Koolwal |
2022 |
Adverse Drug Reactions with Fixed-Dose Combinations In Tuberculosis Patients; 2022, DOI:10.53555/jptcp. v30i17.2782 |
| Dr. Suresh Koolwal |
2022 |
A cross-sectional study to evaluate factors responsible for uncontrolled asthma. Indian J Allergy Asthma Immunol 2022; 36:34-9 |
| Dr. Suresh Koolwal |
2022 |
Adverse Drug Reactions with Fixed-Dose Combinations In Tuberculosis Patients; 2022, DOI:10.53555/jptcp. v30i17.2782 |
| Dr. Suresh Koolwal |
2024 |
An Observational Study to Correlate the Serum Trace Elements Status in Lung Carcinoma, at IRD, SMS Medical College, Jaipur, Rajasthan, India, International Journal of Current Pharmaceutical Review and Research 2024; 16(12); 169-173 |
| Dr. Suresh Koolwal |
2024 |
Malhotra N, Gothi D, Patro M, Kumar R, Anand S, Jain A, et al. Clinicodemographic parameters and outcomes in patients with coronavirus disease 2019 infection during the third wave in India: Is it the end of the pandemic? J Adv Lung Health 2024; 4:70-6. |
| Dr. Suresh Koolwal |
2024 |
Ojha UC, Kumar S, Pal RS, Gothi D, Garg P, Yasaswini G, et al. Sculpting – A modern menace. Indian J Occup Environ Med 2024;28:127-31. |
| Dr. Suresh Koolwal |
2025 |
Study of comparison of medical thoracoscopic guided biopsy versus closed pleural biopsy for etiological diagnosis of undiagnosed exudative pleural effusions: A randomized controlled study: Indian journal of tuberculosis 72 (2025) 32 e37 |
| Dr. Suresh Koolwal |
2025 |
Kumar R, Gothi D, Malhotra N, et al. Diagnostic yield and complications of thoracic ultrasound-guided biopsy performed by pulmonologists. Monaldi Arch Chest Dis doi:10.4081/monaldi.2025.3406 |
| Dr. Suresh Koolwal |
2025 |
Cross-sectional study of pulmonary hypertension among patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis doi: 10.4081/monaldi.2025.3534 |
| Dr. Suresh Koolwal |
2025 |
Suthawal DK, Rajawat GS, Koolwal S, Chaudhary K. Utility of RAPID score in parapneumonic effusion or empyema: A prospective study at a tertiary centre. Lung India 2025; 42:97-102. |
| Dr. Suresh Koolwal |
2025 |
Cross-sectional study of pulmonary hypertension among patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis doi: 10.4081/ monaldi. 2025.3534 |
| Dr. Suresh Koolwal |
2025 |
Utility of RAPID score in parapneumonic effusion or empyema: A prospective study at a tertiary centre. Lung India 2025; 42:97-102. |